Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions2007 · 137 citations
2. 2Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica2003 · 133 citations
3. 3Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update2007 · 1,694 citations
4. 4The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years2009 · 629 citations